Dissolution testing for poorly soluble drugs: A continuing perspective

Dissolution Technologies

Volumn 17, Issue 3, 2010, Pages 24-32

  Gowthamarajan, K ^a   Singh, Sachin Kumar ^b  

^a JSS COLLEGE OF PHARMACY   (India)

^b BHARATHI COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ATOVAQUONE; BETA CYCLODEXTRIN; CHLORAMPHENICOL PALMITATE; DODECYL SULFATE SODIUM; GLYCEROL; GRISEOFULVIN; IONIC SURFACTANT; MACROGOL; MACROGOL 20000; MACROGOL 4000; MACROGOL 6000; MICROCRYSTALLINE CELLULOSE; NANOCRYSTAL; NONIONIC SURFACTANT; PACLITAXEL; PARACETAMOL; PHOSPHATIDYLCHOLINE; POLOXAMER; POLYSORBATE; POLYSORBATE 20; POLYSORBATE 40; POLYSORBATE 60; POLYSORBATE 80; POVIDONE; PROPYLENE GLYCOL; SUCCINIC ACID; TAUROCHOLIC ACID; UNINDEXED DRUG; UREA;

ARTICLE; COMPLEX FORMATION; DRUG BIOAVAILABILITY; DRUG INDUSTRY; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; MICROEMULSION; PARTICLE SIZE; PH; VALIDATION PROCESS;

EID: 78649710378     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT170310P24     Document Type: Article

References (51)

1. Dissolution Testing of Immediate Release Solid Oral Dosage Forms; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, U.S. Government Printing Office: Washington, DC, 1997.
2. Brown, C.; Chokshi, H.; Nickerson, B.; Reed, R.; Rohrs, B.; Shah, P. Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds. Pharm. Technol. 2004, 28 (12), 56-65.
3. Ohara, T.; Kitamura, S.; Kitagawa, T.; Terada, K. Dissolution Mechanism of Poorly Water Soluble Drugs from Extended Solid Dispersion System with Ethyl Cellulose and Hydroxypropyl Methyl Cellulose. Int. J. Pharm. 2005, 302, 95-102.
4. Lipinski, C. Poor aqueous solubility-an industry wide problem in drug discovery. Am. Pharm. Rev. 2002, 5, 82-85.
5. Rohrs, B. Dissolution Method Development of Poorly Soluble Compounds. Dissolution Technol. 2001, 8 (3), 1-5.
6. Noory, C.; Tran, N.; Ouderkirk, L.; Brown, S.; Perry, J.; Lopez, J.; Colon, M.; Henry, K.; Roberg, J.; Nasir, S.; Shah, V. Rethinking the Use of Water as a Dissolution Medium. Dissolution Technol. 1999, 6 (4), 6-7.
7. United States Pharmacopeia and National Formulary USP 29-NF 24; The United Pharmacopeial Convention, Inc.: Rockville, MD, 2006.
8. Leeson, J. L. Some Observations on 'Rethinking the Use of Water as Dissolution Medium.' Dissolution Technol. 2000, 7 (2), 16-17.
9. Zoeller, T.; Klein, S. Simplified Biorelevent Media for Screening Dissolution Performance of Poorly Soluble Drugs. Dissolution Technol. 2007, 14 (4), 8-13.
10. Noory, C.; Tran, N.; Ouderkirk, L.; Shah, V. Steps for Development of a Dissolution Test for Sparingly Water Soluble Produc ts. Dissolution Technol. 2000, 7 (1), 1-5.
11. Kornblum, S.; Hirschorn, J. Dissolution of poorly water-soluble drugs I: Some physical parameters related to method of micronization and tablet manufacture of a quinazolinone compound. J. Pharm Sci. 1970, 59 (5), 607-609.
12. Subrahmanyam, C. V. S. Dissolution. In Textbook of Physical Pharmaceutics, 2nd ed.; Jain, M. K., Ed.; Vallabh Prakashan: Delhi, India, 2000; pp 1, 92.
13. Bergeson, L. L.; Cole, M. F. NanoBioConvergence- Emerging Diagnostic and Therapeutic Applications. Bioprocessing and Biopartnering 2006: Featuring NanoBiotechnology, 2006; http://www.touchbriefings.com/cdps/cditem.cfm?nid=1920&cid=5 (accessed Jul 12, 2010).
14. Valizadeh, H.; Nokhodchi, A.; Qarakhani, N. Physicochemical characterization of solid dispersions of indomethacin PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev. Ind. Pharm. 2004, 30, 303-317.
15. Keck, C. M.; Müller, R. H. Drug nanocrystals of poorly soluble drugs produced by high-pressure homogeni-sation. Eur. J. Pharm. Biopharm. 2006, 62, 3-16.
16. Kirupakar, B. R. Nanosuspension drug delivery: Technology and application. Express Pharma Pulse [Online], Feb 24, 2005. http://www.expresspharmaonline.com/20050224/nanotech01.shtml (accessed Jul 12, 2010).
17. Medical Design Technology Home Page. http://www. mdtmag.com; Microfluidics Home Page. http://www.microfluidicscorp.com (accessed Jul 12, 2010).
18. Arends, B. J.; Blindt, R. A.; Janssen, J.; Patrick, M. Crystallization process using ultrasound. U.S. Patent 6,630,185, Oct 7, 2003.
19. Kakumanu, V. K.; Bansal, A. K. Supercritical Fluid Technology in Pharmaceutical Research. Businessbriefing: Labtech. 2004, 70-72.
20. Pasquali, I.; Bettini, R.; Giordano, F. Solid-State Chemistry and Particle Engineering with Supercritical Fluids in Pharmaceutics. Eur. J. Pharm. Sci. 2006, 27, 299-310.
21. Spray drying. Wikipedia. http://en.wikipedia.org/wiki/Spray_drying (accessed Jul 12, 2010).
22. Kawashima, Y.; Saito, M.; Takenaka, H. Improvement of solubility and dissolution rate of poorly water-soluble salicylic acid by a spray-drying technique. J. Pharm. Pharmacol. 1975, 27 (1), 1-5.
23. NanoMorph Technology for Amorphous Nanoparticles. http://www.soliqs.com/NanoMorph-R.20.0.html (accessed Jul 12, 2010).
24. Brahamankar, D. M.; Jaiswal, S. B. Bioavailability and Bioequivalence. In Biopharmaceutics and Pharmacokinetics: A Treatise, 1st ed.; Vallabh Prakashan: Delhi, India, 1995; p 298.
25. Brahamankar, D. M.; Jaiswal, S. B. Bioavailability and Bioequivalence. In Biopharmaceutics and Pharmacokinetics: A Treatise, 1st ed.; Vallabh Prakashan: Delhi, India, 1995; p 299.
26. Sekiguchi, K.; Obi, N. Studies on absorption of eutectic mixtures. I. A comparison of the behavior of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man. Chem. Pharm. Bull., 1961, 9, 866-872.
27. Sekiguchi, K.; Obi, N.; Ueda, Y. Studies on Absorption of Eutectic Mixtures. II. Absorption of Fused Conglomerates of Chloramphenicol and Urea in Rabbits. Chem. Pharm. Bull. 1964, 12, 134-144.
28. Higuchi, T.; Dayal, S.; Pitman, I. Effects of Solute Solvent Complexation Reaction on Dissolution Kinetics: Testing of a Model By Using a Concentration Jump Technique. J. Pharm. Sci. 1972, 61 (5), 695-700.
29. Tachibana, T.; Nakamura, A.; Kolloid, Z. A method for preparing an aqueous colloidaldispersion of organic materials by using water-soluble polymers-dispersion of beta-carotene by polyvinylpyrrolidone. Kolloid-Z Polym., 1965, 203, 130-133.
30. Mayersohn, M.; Gibaldi, M. New Method of Solid State Dispersion for Increasing Dissolution Rates. J. Pharm. Sci. 1966, 55, 1323.
31. Chiou, W.; Riegelman, S. Preparation and Dissolution Characteristics of Several Fast Release Solid Dispersion of Griseofulvin. J. Pharm. Sci. 1969, 58, 1505.
32. Chiou, W.; Riegelman, S. Pharmaceutical Applications of Solid Dispersion Systems. J. Pharm. Sci. 1971, 60, 1281.
33. Chiou, W.; Riegelman, S. Absorption characteristics of solid dispersed and micronized griseofulvin in man. J. Pharm. Sci. 1971, 60 (9), 1376-1380.
34. Deshpande, A.; Agrawal, D. Increasing the Dissolution Rate of Some Benzothiadiazine Derivatives by Solid and Liquid Dispersion Techniques. Drug Dev. Ind. Pharm. 1982, 8, 883.
35. Takai, T.; Takayama, K.; Nagai, T. Factors affecting the dissolution of griseofulvin dispersed in various water soluble polymers. Chem. Pharm. Bull. 1984, 32, 1936.
36. Cohen, J.; Lach, J. L. Interaction of pharmaceuticals with schardinger dextrins I. Interaction with hydroxybenzoic acids and p-hydroxybenzoates. J. Pharm. Sci. 1963, 52 (2), 132-136.
37. Lach, J. L.; Cohen, J. Interaction of pharmaceuticals with schardinger dextrins II. Interaction with selected compounds. J. Pharm. Sci. 1963, 52 (2), 137-142.
38. Kurozumi, M.; Nambu, N.; Nagai, T. Inclusion compounds of non-steroidal anti-inflammatory and other slightly suitable drugs with α and β cyclodextrins. Chem. Pharm. Bull. 1975, 23, 3062-3068.
39. Uekama, K. Pharmaceutical applications of methylated cyclodextrins. Pharm. Int. 1985, 3, 61-65.
40. Harata, K.; Uekama, K.; Otagiri, M.; Hirayama, F.; Sugiyama, Y. Bull. Chem. Soc. Japan 1982, 55, 3386-3389.
41. Uekama, K.; Imai, T.; Maeda, T.; Irie, T.; Hirayama, F.; Otagiri, M. Improvement of dissolution and supporting release characteristics of flurbiprofen by inclusion complexation with heptakis (2, 6-di-o-methyl)-β-cyclodextrin. J. Pharm. Sci. 1985, 74, 841.
42. Zerrouk, N.; Corti, G.; Ancillotti, S.; Mastrelli, F.; Cirri, M.; Murra, P. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur. J. Pharm. Biopharm. 2006, 62 (3), 241-246.
43. Harada, A.; Furue, M.; Nozakura, S. Inclusion of aromatic compounds by a β-cyclodextrin-epichlorhydrin polymer. Polym. J. 1981, 13, 777.
44. Uekama, K.; Otagiri, M.; Irie, T.; Seo, H.; Tsuruoka, M. Improvement of Dissolution and Absorption Characteristics of Phenytoin by a Water Soluble β-Cyclodex trin-Epichlorhydrin Polymer. Int. J. Pharm. 1985, 23, 25.
45. Lawrence, M. J.; Rees, G. D. Microemulsion-based media as novel drug delivery systems. Adv. Drug Del. Rev. 2000, 45, 89-121.
46. Ahuja, S.; Ahuja, A.; Baboota, S.; Ali, J. Dissolution: A promising Tool in Drug Delivery. Indian J. Pharm. Sci. 2005, 67 (6), 650-660.
47. Yousef, J.; Jafari, B.; Nokhodchi, A. Liquisolid Technique for Disolution Rate Enhancement of A High Dose Water Insoluble Carbamazepine. Int. J. Pharm. 2007, 341, 26-34.
48. Yousef, J.; Siahi, M. R.; Barzegar M.; Nokhodchi, A. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Farmaco, 2005, 60, 361-365.
49. Tiong, N.; Elkordy A. A. Effect of Liquisolid Formulations on Dissolution of Naproxen. Eur. J. Pharm. Biopharm. 2009, 73, 373-384.
50. Fahmy, R. H.; Kaseem, M. A. Enhancement of Famotidine Dissolution Rate through Liquisolid Tablet Formulation: In Vitro-In Vivo Equation. Eur. J. Pharm. Biopharm. 2008, 69, 993-1003.
51. Spireas, S.; Sadu, S. Enhancement of Prednisolone Dissolution Property using Liquisolid Compacts. Int. J. Pharm.1998, 166, 177-188.